Phase IIa Efficacy and Safety Trial of Capadenoson in Patients With Chronic Stable Angina.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 26 Feb 2017
At a glance
- Drugs Capadenoson (Primary)
- Indications Angina pectoris
- Focus Therapeutic Use
- Sponsors Bayer
- 24 Apr 2014 Last checked against ClinicalTrials.gov record.
- 14 Aug 2008 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 14 Aug 2008 Planned initiation date changed from 1 Oct 2007 to 1 Dec 2007 as reported by ClinicalTrials.gov.